Search Results for "New Treatment For Hepatitis B"

03:27 EDT 19th October 2017 | BioPortfolio

Matching Channels

Hepatitis B

Hepatitis A

Hepatitis C

Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV R...

Hepatitis E virus HEV

Hepatitis B virus HBV

Matching News

Eliminate hepatitis: WHO

New WHO data from 28 countries - representing approximately 70% of the global hepatitis burden - indicate that efforts to eliminate hepatitis are gaining momentum. Published to coincide with World H...

Japan Approves 8-Week Treatment for Genotype 1 and 2 Hepatitis C Virus

NewsEnanta announces that AbbVie’s Maviret glecaprevir/pibrentasvir received approval in Japan for the treatment of all major genotypes (GT1-6) of chronic hepatitis C. Japan has one of the highest r...

Nine in 10 people unaware they have hepatitis

The WHO has released a report on the state of hepatitis prevention and treatment to mark World Hepatitis Day, with an emphasis that much work is left to be done to combat the viral infection. The org...

Hepatitis Barriers to Care Focus of ICVH 2017

Efforts to improve screening for hepatitis C and access to treatment, especially for high-risk populations, will be in the spotlight at the upcoming International Conference on Viral Hepatitis (ICVH)....

Around 9 million Europeans are affected by chronic hepatitis B or C

An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million (3.9) with chronic hepatitis C infection. However, large numbers of them are not even aware of their infecti...

Canada approves AbbVie's Maviret as treatment for hepatitis C

Maviret, AbbVie's glecaprevir/pibrentasvir drug developed as a treatment for adults with chronic hepatitis C virus across gen -More- 

ECDC estimate: Around 9 million Europeans are affected by chronic hepatitis B or C

(European Centre for Disease Prevention and Control (ECDC) ) An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million with chronic hepatitis C infection. But large ...

Groups issue updated guidelines on hepatitis C diagnosis, treatment

Information on new resources and additional guidelines on the diagnosis and treatment of hepatitis C has been added to the we -More- 

Matching PubMed Articles

Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar.

In Myanmar, over five million people are infected with hepatitis B virus (HBV) and hepatitis C virus (HCV). Hepatitis has been a recent focus with the development of a National Strategic Plan on Hepat...

Durability of Response After Hepatitis B Surface Antigen Seroclearance During Nucleos(t)ide Analogue Treatment in a Multiethnic Cohort of Chronic Hepatitis B Patients: Results After Treatment Cessation.

In 70 chronic hepatitis B patients with hepatitis B surface antigen seroclearance during nucleos(t)ide analogue therapy, response was sustained in all 54 patients who discontinued treatment. Clinicall...

Deciphering molecular properties and docking studies of hepatitis C and non-hepatitis C antiviral inhibitors - A computational approach.

Hepatitis C is an infectious liver disease with high mortality rate which is caused by Hepatitis C virus. Several treatment methods have been applied to combat this deadly virus including interferons,...

Diagnosis of viral hepatitis.

Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections and HIV-HBV and HCV coinfection are major causes of chronic liver disease worldwide. Testing and diagnosis is the gateway for acc...

Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients.

We aimed to clarify the association of HBsAg/HBcAg with the disease status and treatment response in patients with chronic hepatitis B (CHB).

Search Whole site using Google

Quick Search
Advertisement Advertisement